Last week alone, there were three major consolidations in the pharmaceutical space: Teva will acquire the generic business of Allergan Hikma pharmaceuticals will acquire Roxane, Boehringer Ingelheim’s generic drug business Mylan will acquire Perrigo These three deals in just a few days reflect the trend of pharmaceutical consolidation as companies seek new products in order to …
NY Times – DealB%k
- Sign Up for DealBook December 21, 2024Make sense of the latest business and policy headlines with our daily newsletter.
- From Inflation to Bitcoin, 9 Charts That Explain 2024 December 21, 2024Rate cuts, stock surges, and Trump’s tariff threats are among the biggest forces shaping business and the economy.
- Google Proposes Fix to Solve Search Monopoly December 21, 2024The search giant’s proposals included allowing flexibility for companies and consumers in choosing a search engine.